Skip to content

Capecitabine 2-O-BDR Impurity (USP)

Capecitabine 2-O-BDR Impurity (USP)

Product Description
CAT No.
ALN-C003009
CAS No.
1262133-66-3
Mol. F.
C20H30FN3O9
Mol. Wt.
475.5
Stock
Please Inquire
RFQ
Chemical Name : [1-[5-Deoxy-2-O-(5-deoxy-β-d-ribofuranosyl)-β-d-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester (as per USP)
Smiles : O=C(OCCCCC)NC(C(F)=CN1[C@H]2[C@@H]([C@@H]([C@@H](C)O2)O)O[C@H]3[C@@H]([C@@H]([C@@H](C)O3)O)O)=NC1=O

Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry

By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, ShaileshnFrom American Journal of PharmTech Research (2020), 10(6), 115-133

Validated stability indicating HPLC method for estimation of capecitabine

By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N. – From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658

RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)

By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K. – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67

Request For Quotation

Related Products